• Login
    View Item 
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    A randomized phase 2/3 study of naptumomab estafenatox + IFN-α vs IFN-α in renal cell carcinoma: final analysis with baseline biomarker subgroup and trend analysis

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    537610.pdf
    Size:
    924.2Kb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Hawkins, Robert E
    Gore, M
    Shparyk, Y
    Bondar, V
    Gladkov, O
    Ganev, T
    Harza, M
    Polenkov, S
    Bondarenko, I
    Karlov, P
    Karyakin, O
    Khasanov, R
    Hedlund, G
    Forsberg, G
    Nordle, O
    Eisen, T
    Show allShow less
    Affiliation
    Medical Oncology, Christie CRC Research Centre
    Issue Date
    2016-02-05
    
    Metadata
    Show full item record
    Abstract
    To prospectively determine the efficacy of naptumomab estafenatox (Nap) + interferon α (IFN) versus IFN in metastatic renal cell carcinoma (RCC).
    Citation
    A randomized phase 2/3 study of naptumomab estafenatox + IFN-α vs IFN-α in renal cell carcinoma: final analysis with baseline biomarker subgroup and trend analysis. 2016: Clin Cancer Res
    Journal
    Clinical Cancer Research
    URI
    http://hdl.handle.net/10541/600545
    DOI
    10.1158/1078-0432.CCR-15-0580
    PubMed ID
    26851187
    Type
    Article
    Language
    en
    ISSN
    1078-0432
    ae974a485f413a2113503eed53cd6c53
    10.1158/1078-0432.CCR-15-0580
    Scopus Count
    Collections
    All Paterson Institute for Cancer Research

    entitlement

    Related articles

    • Immunological response and overall survival in a subset of advanced renal cell carcinoma patients from a randomized phase 2/3 study of naptumomab estafenatox plus IFN-α versus IFN-α.
    • Authors: Elkord E, Burt DJ, Sundstedt A, Nordle Ö, Hedlund G, Hawkins RE
    • Issue date: 2015 Feb 28
    • Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206.
    • Authors: Rini BI, Halabi S, Rosenberg JE, Stadler WM, Vaena DA, Archer L, Atkins JN, Picus J, Czaykowski P, Dutcher J, Small EJ
    • Issue date: 2010 May 1
    • Bevacizumab plus interferon-α versus sunitinib for first-line treatment of renal cell carcinoma in Italy: a cost-minimization analysis.
    • Authors: Ravasio R, Ortega C, Sabbatini R, Porta C
    • Issue date: 2011
    • Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma.
    • Authors: Escudier B, Szczylik C, Hutson TE, Demkow T, Staehler M, Rolland F, Negrier S, Laferriere N, Scheuring UJ, Cella D, Shah S, Bukowski RM
    • Issue date: 2009 Mar 10
    • Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206.
    • Authors: Rini BI, Halabi S, Rosenberg JE, Stadler WM, Vaena DA, Ou SS, Archer L, Atkins JN, Picus J, Czaykowski P, Dutcher J, Small EJ
    • Issue date: 2008 Nov 20
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.